Comparing Enhanced Cognitive-behavior Therapy and Family-based Treatment for Adolescents With an Eating Disorder

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age12-18
SponsorOslo University Hospital

About this trial

The goal of this randomized controlled clinical trial is to compare the efficacy of outpatient family-based treatment versus enhanced cognitive behavior therapy for children and adolescents with eating disorders.

Because of insufficient recruitment, the study design was modified on December 1st, 2025, to a partially randomized preference design.

The main aim is to determine if enhanced cognitive behavior therapy has a similar efficacy as family-based treatment among children and adolescents with eating disorders receiving treatment in an outpatient setting. The main outcome is improvement in eating disorders psychopathology at the end of treatment.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Diagnostic and Statistical Manual of Mental Disorders (DSM-5) diagnosed eating disorder

Medically stable for outpatient treatment.

Living with at least one of their parents

At least one of their parents could be actively involved in the treatment

Disqualifiers

Avoidant restrictive food intake disorders

A co-morbid medical condition or disorder known to influence eating or weight, or influence the possibilities to take part in treatment

Psychotic disorders

Acute suicidality

Trial design

Design model

Parallel

Treatments tested in this trial

  • Enhanced Cognitive-behavior therapy for adolescents with an eating disorder

    Behavioral

    Psychotherapy

  • Family-based therapy for adolescents with an eating disorder

    Behavioral

    Psychotherapy

Treatment groups

200 Participants
are divided into 2 treatment groups
Group A: Enhanced cognitive-behavior therapy for adolescents with an eating disorder (CBT-E)Experimental treatment 1 intervention
Group B: Family-based treatment for adolescents with an eating disorder (FBT)Active comparator 1 intervention

Trial outcomes

Primary outcomes

1

Change in eating disorder psychopathology

Change in global scores on a well-validated semi-structured interview of eating disorder attitudes and behavior, the Eating Disorder Examination - Interview. Possible scores range from 0-6 where higher scores indicate worse symptoms.

Time frame
Baseline, immediately after the intervention.

Secondary outcomes

1

Change in eating disorder psychopathology

Change in global and subscale scores on a well-validated self-report questionnaire of eating disorder attitudes and behavior, the Eating Disorder Examination-Questionnaire. Possible scores range from 0-6 where higher scores indicate worse symptoms.

Time frame
Baseline, immediately after the intervention, 6 months after the end of treatment, 12 months after the end of treatment.
2

Change in weight (kg) for underweight participants (defined as those participants who are below 18,5 Body Mass Index (BMI) (kg/m2) at baseline or corresponding BMI to age and gender).

Weight gain in kilogram. Higher weight gain means better outcome.

Time frame
Baseline, immediately after the intervention, 6 months after the end of treatment, 12 months after the end of treatment
3

Change in depression

Change in global score on a well-validated self-report questionnaire of depression, the Beck Depression Inventory II. Possible scores range from 0 to 63 where higher scores mean worse symptoms.

Time frame
Baseline, immediately after the intervention, 6 months after the end of treatment, 12 months after the end of treatment
4

Change in anxiety

Change in global score on a well-validated self-report questionnaire of anxiety, the Beck Anxiety Inventory. Possible scores range from 0 to 63 where higher scores mean worse symptoms.

Time frame
Baseline, immediately after the intervention, 6 months after the end of treatment, 12 months after the end of treatment

Other outcomes

1

Changes in family function

Change in parent ratings of family functioning measured by the subscale score on a well validated self-report questionnaire- the McMaster Family Assessment Device, General Functioning subscale. Scores on this subscale range from 12 to 48, where higher scores means worse level of family function.

Time frame
Baseline, immediately after the intervention, 6 months after the end of treatment, 12 months after the end of treatment
2

Changes caregiving experience and psychological symptoms

Change in parent ratings on the impact of eating disorder symptoms on caregiving experiences measured by a well validated, self-report measure -the Eating Disorders Symptom Impact Scale. Scores range from 0 to 96, where higher scores mean worse impact of eating disorder symptoms.

Time frame
Baseline, immediately after the intervention, 6 months after the end of treatment, 12 months after the end of treatment
3

Changes caregiving mental health

Change in parent ratings on the mental health symptoms by a well validated, self-report measure -the Hopkins symptoms checklist 25 items. Scores range from 1 to 4 where higher scores mean worse mental health symptoms.

Time frame
Baseline, immediately after the intervention, 6 months after the end of treatment, 12 months after the end of treatment
4

Direct and indirect costs of health care use for patients and parents/caregivers

Register data from the Norwegian Control and Payment of Health Reimbursements Database (KUHR), the Norwegian Patient Registry (NPR), and Social Security Database.

Time frame
Baseline, immediately after the intervention, 6 months after the end of treatment, 12 months after the end of treatment

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Oslo University Hospital

Lead sponsor

South-Eastern Norway Regional Health Authority

Collaborator

University of Oslo

Collaborator

Villa Garda Hospital

Collaborator

University of California, San Francisco

Collaborator

St. Olavs Hospital

Collaborator

University Hospital of North Norway

Collaborator

Haukeland University Hospital

Collaborator

Vestre Viken Hospital Trust

Collaborator